{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:08:41Z","timestamp":1760382521232},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1006\/bbrc.2002.6685","type":"journal-article","created":{"date-parts":[[2003,4,24]],"date-time":"2003-04-24T17:03:32Z","timestamp":1051203812000},"page":"519-529","source":"Crossref","is-referenced-by-count":32,"title":["Mechanistic Studies on AMD6221: A Ruthenium-Based Nitric Oxide Scavenger"],"prefix":"10.1006","volume":"292","author":[{"given":"R.","family":"Mosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Amankwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Darkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.P.","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/bbrc.2002.6685_RF1","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/bbrc.2002.6685_RF2","doi-asserted-by":"crossref","first-page":"12231","DOI":"10.1016\/S0021-9258(18)31375-9","article-title":"Nitric oxide synthase structure and mechanism","volume":"268","author":"Marletta","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bbrc.2002.6685_RF3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem. J."},{"key":"10.1006\/bbrc.2002.6685_RF4","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1021\/jm00022a001","article-title":"Nitric oxide: A new paradigm for second messengers","volume":"38","author":"Kerwin","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1006\/bbrc.2002.6685_RF5","first-page":"2","article-title":"Alterations in nitric oxide production in various forms of circulatory shock","volume":"3","author":"Szabo","year":"1995","journal-title":"New Horizons"},{"key":"10.1006\/bbrc.2002.6685_RF6","first-page":"493","article-title":"Nitric oxide. A key mediator in sepsis and endotoxaemia?","volume":"48","author":"Parratt","year":"1997","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1006\/bbrc.2002.6685_RF7","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/jm00039a001","article-title":"Approaches toward selective inhibition of nitric oxide synthase","volume":"37","author":"Marletta","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1006\/bbrc.2002.6685_RF8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1367-5931(98)80125-7","article-title":"Design of isoform-selective inhibitors of nitric oxide synthase","volume":"2","author":"Babu","year":"1998","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1006\/bbrc.2002.6685_RF9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/PL00005233","article-title":"Nitric oxide synthases: Catalytic function and progress towards selective inhibition","volume":"358","author":"Mayer","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1006\/bbrc.2002.6685_RF10","series-title":"Nitrogen Monoxide-Related Disease and Nitrogen Monoxide Scavengers as Potential Drugs","author":"Fricker","year":"1999"},{"key":"10.1006\/bbrc.2002.6685_RF11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/a606463i","article-title":"Kinetics of nitric oxide scavenging by ruthenium(III) polyaminocarboxylates: Novel therapeutic agents for septic shock","author":"Davies","year":"1997","journal-title":"Chem. Commun."},{"key":"10.1006\/bbrc.2002.6685_RF12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/sj.bjp.0701504","article-title":"Ruthenium complexes as nitric oxide scavengers: A potential therapeutic approach to nitric oxide-mediated diseases","volume":"122","author":"Fricker","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2002.6685_RF13","first-page":"84","article-title":"A novel ruthenium-based nitric oxide scavenger ameliorates acute lung injury in porcine endotoxemia","volume":"48","author":"Baggs","year":"1997","journal-title":"Surg. Forum."},{"key":"10.1006\/bbrc.2002.6685_RF14","first-page":"776","article-title":"Ruthenium-based nitric oxide scavengers inhibit tumour growth by reducing tumour vasculature","volume":"17","author":"Pritchard","year":"1999","journal-title":"Clin. Exp. Metast."},{"key":"10.1006\/bbrc.2002.6685_RF15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1053-2498(00)00276-X","article-title":"A ruthenium(III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection","volume":"20","author":"Pieper","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"10.1006\/bbrc.2002.6685_RF16","doi-asserted-by":"crossref","DOI":"10.1097\/00005344-200203000-00016","article-title":"A ruthenium(III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection","author":"Pieper","year":"2002","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1006\/bbrc.2002.6685_RF17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/ic50034a004","article-title":"Hexaaquoruthenium(III)","volume":"4","author":"Mercer","year":"1965","journal-title":"Inorg. Chem."},{"key":"10.1006\/bbrc.2002.6685_RF18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1006\/bbrc.2002.6685_RF19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","article-title":"Functional macrophage cell lines transformed by Abelson leukemia virus","volume":"15","author":"Raschke","year":"1978","journal-title":"Cell"},{"key":"10.1006\/bbrc.2002.6685_RF20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1006\/bbrc.2002.6685_RF21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/abio.1993.1341","article-title":"A spectrophotometric assay for nitrate using NADPH oxidation by aspergillus nitrate reductase","volume":"212","author":"Gilliam","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1006\/bbrc.2002.6685_RF22","unstructured":"Schmidt, H. H. H, and, Kelm, M. 1996, Determination of nitrite and nitrate by the Griess reaction, John Wiley and Sons, Chichester, UK."},{"key":"10.1006\/bbrc.2002.6685_RF23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/niox.1997.0116","article-title":"Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate, and s-nitrosothiols","volume":"1","author":"Marzinzig","year":"1997","journal-title":"Nitric Oxide"},{"key":"10.1006\/bbrc.2002.6685_RF24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/niox.1999.0240","article-title":"Quantification of iNOS mRNA with reverse transcription polymerase chain reaction directly from cell lysates","volume":"3","author":"Han","year":"1999","journal-title":"Nitric oxide Biol. Chem."},{"key":"10.1006\/bbrc.2002.6685_RF25","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1073\/pnas.88.17.7773","article-title":"Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein","volume":"88","author":"Stuehr","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bbrc.2002.6685_RF26","unstructured":"Leatherbarrow, R. 1989, Grafit 4.0.12, Erithacus Software Ltd. Staines, UK."},{"key":"10.1006\/bbrc.2002.6685_RF27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1113\/expphysiol.1993.sp003687","article-title":"Nitric oxide and cardiovascular control","volume":"78","author":"Calver","year":"1993","journal-title":"Exp. Physiol."},{"key":"10.1006\/bbrc.2002.6685_RF28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00003246-199905000-00025","article-title":"An open label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock","volume":"27","author":"Grover","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1006\/bbrc.2002.6685_RF29","doi-asserted-by":"crossref","first-page":"33A","DOI":"10.1097\/00003246-199901001-00021","article-title":"Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock","volume":"27","author":"Grover","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1006\/bbrc.2002.6685_RF30","first-page":"795","article-title":"Use of nitric oxide synthase inhibitors for the treatment of inflammatory disease and pain","volume":"4","author":"Cheshire","year":"2001","journal-title":"IDrugs"},{"key":"10.1006\/bbrc.2002.6685_RF31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00003246-199905000-00002","article-title":"Use of nitric oxide synthase inhibitors to treat septic shock: The light has changed from yellow to red","volume":"27","author":"Cobb","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1006\/bbrc.2002.6685_RF32","unstructured":"Cameron, B. R, Bridger, G. J, Davies, N. A, Fricker, S. P, Abrams, M. J, Rose, D. J, Wilson, M. T, and, Zubieta, J. 1998, Ruthenium complexes as scavengers of nitric oxide. XXXIII International Conference on Coordination Chemistry."},{"key":"10.1006\/bbrc.2002.6685_RF33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/0003-4975(92)90113-I","article-title":"Release of vasoactive substances during cardiopulmonary bypass","volume":"54","author":"Downing","year":"1992","journal-title":"Ann. Thorac. Surg."},{"key":"10.1006\/bbrc.2002.6685_RF34","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1378\/chest.106.5.1364","article-title":"Reversible diastolic dysfunction after successful coronary artery bypass surgery. Assessment by transesophageal doppler echocardiography","volume":"106","author":"Gorson","year":"1994","journal-title":"Chest"},{"key":"10.1006\/bbrc.2002.6685_RF35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0022-5223(99)70383-1","article-title":"Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by s-nitrosoglutathione","volume":"117","author":"Mayers","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1006\/bbrc.2002.6685_RF36","doi-asserted-by":"crossref","unstructured":"Mayers, I, Hurst, T, Radomski, A, Johnson, D, Fricker, S. P, Bridger, G. J, Cameron, B, Darkes, M, and, Radomski, M. W. 2002, Increased matrix metalloproteinase activity following canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger. Submitted for publication.","DOI":"10.1067\/mtc.2003.38"},{"key":"10.1006\/bbrc.2002.6685_RF37","unstructured":"Yasuda, N, MacFarland, R, Darkes, M, and, Fricker, S. P. 2000, Pharmacokinetics and tissue distribution of a ruthenium-based nitric oxide scavenger in the rat. 21st Annual Meeting of the American College of Toxicology."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X02966854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X02966854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T05:37:07Z","timestamp":1620020227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X02966854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0006291X02966854"],"URL":"https:\/\/doi.org\/10.1006\/bbrc.2002.6685","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}